BURCON NUTRASCIENCE CORP (BU.CA) Stock Price, Forecast & Analysis
Canada - Toronto Stock Exchange - TSX:BU - CA1208313009 - Common Stock
BU.CA Key Statistics, Chart & Performance
The current stock price of BU.CA is 1.84 CAD. In the past month the price increased by 1.1%. In the past year, price increased by 15%.
BU.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| AIM-PR-C.CA | AIMIA INC - AIMCN 7.773 PERP | N/A | 2.03B | ||
| AIM-PR-A.CA | AIMIA INC - AIMCN 6.363 PERP | N/A | 1.86B | ||
| VNP.CA | 5N PLUS INC | 27.33 | 1.63B | ||
| NEO.CA | NEO PERFORMANCE MATERIALS IN | N/A | 656.45M | ||
| AIM.CA | AIMIA INC | N/A | 249.66M | ||
| ECO.CA | ECOSYNTHETIX INC | N/A | 233.69M | ||
| NANO.CA | NANO ONE MATERIALS CORP | N/A | 126.45M | ||
| AUUA.CA | ALUULA COMPOSITES INC | N/A | 118.39M | ||
| HPQ.CA | HPQ SILICON INC | N/A | 73.94M |
Related stock screener links
About BU.CA
Company Profile
Burcon NutraScience Corp. engages in the development of plant proteins and ingredients for use in the food and beverage industries. The company is headquartered in Vancouver, British Columbia and currently employs 15 full-time employees. The firm has an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. The company is engaged in the production of hemp protein isolate and the provision of contract research services. Its products include hempseed protein, canola protein, pea proteins and protein blends. Its hempseed protein isolate extraction and purification/production process can produce a high-quality protein ingredient that contains 95% pure protein. The company extracts and purifies a canola protein isolate from canola meal. The company has branded this protein isolate under the trade name Puratein C. It provides consulting and contract services, product and process development, and process scale-up and validation. The company also operates a protein production facility located in Galesburg, Illinois.
Company Info
BURCON NUTRASCIENCE CORP
490-999 West Broadway
Vancouver BRITISH COLUMBIA V6J 1Z2 CA
CEO: Johann F. Tergesen
Employees: 25
Phone: 16047330896
BURCON NUTRASCIENCE CORP / BU.CA FAQ
What does BU do?
Burcon NutraScience Corp. engages in the development of plant proteins and ingredients for use in the food and beverage industries. The company is headquartered in Vancouver, British Columbia and currently employs 15 full-time employees. The firm has an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. The company is engaged in the production of hemp protein isolate and the provision of contract research services. Its products include hempseed protein, canola protein, pea proteins and protein blends. Its hempseed protein isolate extraction and purification/production process can produce a high-quality protein ingredient that contains 95% pure protein. The company extracts and purifies a canola protein isolate from canola meal. The company has branded this protein isolate under the trade name Puratein C. It provides consulting and contract services, product and process development, and process scale-up and validation. The company also operates a protein production facility located in Galesburg, Illinois.
Can you provide the latest stock price for BURCON NUTRASCIENCE CORP?
The current stock price of BU.CA is 1.84 CAD. The price increased by 3.95% in the last trading session.
Does BURCON NUTRASCIENCE CORP pay dividends?
BU.CA does not pay a dividend.
What is the ChartMill rating of BURCON NUTRASCIENCE CORP stock?
BU.CA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the Price/Earnings (PE) ratio of BURCON NUTRASCIENCE CORP (BU.CA)?
BURCON NUTRASCIENCE CORP (BU.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.98).
What is the next earnings date for BU stock?
BURCON NUTRASCIENCE CORP (BU.CA) will report earnings on 2026-02-12.
BU.CA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to BU.CA. When comparing the yearly performance of all stocks, BU.CA is a bad performer in the overall market: 80.99% of all stocks are doing better.
BU.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BU.CA. BU.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
BU.CA Financial Highlights
Over the last trailing twelve months BU.CA reported a non-GAAP Earnings per Share(EPS) of -0.98. The EPS decreased by -163.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -45.26% | ||
| ROE | -8604.73% | ||
| Debt/Equity | 104.05 |
BU.CA Forecast & Estimates
For the next year, analysts expect an EPS growth of -803.01% and a revenue growth 153.85% for BU.CA